4.5 Letter

Comparing long-term survival benefits of hepatocellular carcinoma between thermal ablation monotherapy and combined therapy with transarterial chemoembolization: A propensity score matched study

Related references

Note: Only part of the references are listed.
Article Radiology, Nuclear Medicine & Medical Imaging

Comparing Long-Term survival benefits of hepatocellular carcinoma between thermal ablation monotherapy and combined therapy with transarterial Chemoembolization: A propensity score matched study

Ke Zhang et al.

Summary: A study using propensity score matching found no significant difference in long-term survival benefits between thermal ablation monotherapy and thermal ablation combined with transarterial chemoembolization in hepatocellular carcinoma patients.

EUROPEAN JOURNAL OF RADIOLOGY (2023)

Article Medicine, General & Internal

Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma

Myeong Jun Song et al.

KOREAN JOURNAL OF INTERNAL MEDICINE (2016)